KRas takes a different route by Short, Ben
In This Issue
JCB • VOLUME 184 • NUMBER 6 • 2009 766
Text by Ben Short
bshort@rockefeller.edu 
KRas takes a different route
T
he small GTPase 
KRas moves be-
tween different 
membranes within the cell 
by diffusion, but Lu et al. 
fi  nd it can use an alternative 
mode of transport to travel 
to another destination.
Ras proteins control many cellular functions including 
proliferation, differentiation, and apoptosis. Their location within the cell 
affects the downstream signals they send; KRas has been identifi  ed at 
the plasma membrane and on intracellular membranes. Previous reports 
suggested that KRas associates with negatively charged membranes via 
its positively charged C-terminus and moves between compartments by 
diffusing through the cytosol along an electrostatic gradient.
But when Lu et al. tracked GFP-labeled KRas, they discovered 
that the protein moves to early endosomes by internalizing from 
the plasma membrane in clathrin-coated vesicles. Unlike other Ras 
family members, KRas then gets sorted into late endosomes (LEs) 
before traveling to the lysosomes for degradation. Fluorescent 
probes revealed that KRas was active on LEs, where it colocalized 
with a scaffolding complex called p14-MP1 and initiated a MAP 
kinase signaling cascade.
KRas’ journey to the lysosomes is stimulated by EGF and 
its receptor, which share the ride all the way to the end, suggesting 
that lysosomal-degradation may be important for switching off 
the EGF/KRas signal. Indeed, when lysosomal degradation was 
blocked, the MAP kinase cascade remained active for longer on the 
LEs. The researchers now want to look at how LE KRas signaling 
is propagated and determine how it differs from KRas signaling at 
the plasma membrane.
Lu, A., et al. 2009. J. Cell Biol. doi:10.1083/jcb.200807186.
Lipid droplets lead a Spartin existence
S
partin, a protein linked to the neu-
ronal disease Troyer syndrome, was 
thought to function in endocytosis. 
Here, Eastman et al. identify an unexpected 
role for Spartin in regulating the cell’s lipid 
storage depots.
Cells transport excess fats into lipid 
droplets (LDs), where they are kept until 
needed as sources of energy, but little is 
known about LD formation and regulation. 
Spartin hadn’t been connected to LDs. But 
Eastman et al. found that Spartin localizes to LDs and binds to a 
known LD protein called TIP47.
Spartin seems to regulate LD turnover: overexpressing or 
knocking down the protein caused an increase in both the organelle’s 
size and number. In turn, Spartin is regulated by ubiquitination by 
the ubiquitin ligase WWP1. Overexpressed WWP1 removed Spartin 
from LDs and promoted its degradation.
A truncated form of Spartin found in a rare neuronal disease 
called Troyer syndrome didn’t localize to LDs or bind to TIP47. 
It remains to be seen whether defects in LD function are the root 
cause of the defects seen in Troyer patients, but author Paul Bieniasz 
points to precedents of defects in lipid turnover triggering neuronal 
disorders, such as mutations in the phospholipase NTE causing 
motor neuron disease.
Eastman, S.W., et al. 2009. J. Cell Biol. doi:10.1083/jcb.200808041.
Spartin (red) localizes 
on the surface of lipid 
droplets (green).





ing epithelial cells are 
stable and decorated along 
their length by a protein 
called CLASP. Back in the 
cell body, microtubules are 
much more dynamic, and 
CLASP only binds to their 
growing ends. Kumar et 
al. reveal how a gradient 
of phosphorylation by 
GSK3  could cause this switch in CLASP’s behavior.
The kinase activity of GSK3  changes from the front to back of 
migrating cells: low activity at the leading edge but higher in the cell body. 
Since expressing a highly active form of GSK3  completely removes 
CLASP from microtubules, Kumar et al. were interested to see whether 
phosphorylation could have more subtle effects on CLASP’s localization.
The team identifi   ed nine sites in CLASP that could be 
phosphorylated by GSK3  all within a domain called MT#1 that 
recognizes growing microtubule ends. Although other domains are 
required for CLASP’s binding along microtubules, phosphorylation 
of MT#1 was suffi   cient to regulate CLASP’s localization: 
unphosphorylated CLASP bound along the length of microtubules 
while partial phosphorylation promoted its switch to microtubule 
ends. Author Torsten Wittmann thinks that increased CLASP binding 
at the cell front may help stabilize the microtubules by anchoring 
them to the cell cortex. CLASP probably links microtubules to the 
cortex through interactions with other proteins, like LL5b or ACF7, 
that bind to its C terminus; deleting CLASP’s C terminus prevented 
stable cortical attachments from forming.
Many CLASP-stabilized microtubules cluster near focal 
adhesions, where the cell binds to the extracellular matrix. Wittmann 
now plans to investigate what these microtubules actually do: they 
could be involved in adhesion site turnover, or in the transport of 
cargo required for matrix degradation during cell migration.
Kumar, P., et al. 2009. J. Cell Biol. doi:10.1083/jcb.200901042.
Active KRas (red) accumulates on 
endosomes after stimulation with EGF.
GSK3 phosphorylates CLASP, changing 
its localization from all along microtubules 
(left) to exclusive binding at growing 
microtubule plus ends (right).